Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

SOLV

Solventum Corp

Surgical & Medical Instruments & Apparatus · SIC 3841CIK 1964738Held by 7 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$8.33B
Net Income FY2025
$1.56B
EPS (Basic, as reported)
$8.94
Net Margin FY2025
18.7%
ROE FY2025
30.8%
Total Equity
$5.05B
Shares Out
170M
Business description

Solventum Corp — Surgical & Medical Instruments & Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2022–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 8,130 → 8,325 +0.8% CAGR
Fiscal yearFY2022FY2023FY2024FY2025
Revenue8,1308,1978,2548,325
Gross profit4,6954,6934,5934,451
Research & development(767)(758)(775)(739)
Selling, general & administrative(2,235)(2,243)(2,782)(3,080)
Operating income1,6931,6921,0362,181
Other income (expense), net(1)(25)(64)(39)
Pre-tax income1,6921,6676051,713
Income tax expense(349)(321)(127)(157)
Net income1,3431,3464791,556
EPS — basic$7.78$7.79$2.77$8.94
EPS — diluted$7.78$7.79$2.76$8.88
Shares outstanding — basic (M)173173173174
Shares outstanding — diluted (M)173173174175

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.